Status:
NOT_YET_RECRUITING
Cognitive Rehabilitation for People With Multiple Sclerosis
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
25-65 years
Phase:
NA
Brief Summary
Cognitive rehabilitation is designed to enhance a person's capacity to process and interpret information and improve their ability to function in all aspects daily, family and community life. Given th...
Detailed Description
Background: Multiple sclerosis (MS) is a chronic disabling disease of the central nervous system, with symptom onset commonly occurring between the ages of 20 to 40 years old; with females being at a...
Eligibility Criteria
Inclusion
- A define diagnosis of multiple sclerosis (which will include clinically isolate syndrome, radiologically isolated syndrome and neuromyelitis optica spectrum disorder).
- A performance below 1.5 or 2 standard deviations (SD) compared to the normative mean in at least 20-30% of the test parameters.
- Corrected near vision of 20/70 or better (to see test material)
Exclusion
- Exclude persons with a history of central nervous system disease other than MS
- Use of illicit drugs, phencyclidine (PCP), Lysergic acid diethylamide (LSD), stimulants, amphetamines, barbiturates, etc. (Cannabis use is accepted)
- Psychotic symptoms, bipolar disorder, schizophrenia
- Exclude persons who have used steroids within the past 3 months
- Exclude persons unable or unwilling to travel to the Centre or requires transportation by ambulance.
Key Trial Info
Start Date :
June 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06179134
Start Date
June 3 2024
End Date
January 31 2025
Last Update
April 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anthony Feinstein
Toronto, Ontario, Canada, M4Y 2P9